The Skin Beneath the Skin You Can See.
Our Peel Portfolio — Not all peels are the same, and not all skin concerns require the same peel. The clinical value of Ministry of Skin's peel programme lies in the breadth and specificity of the options available — and in the dermatologist's ability to select, formulate, and apply the most appropriate one for your specific presentation.
Overview
Most people who come to Ministry of Skin with a skin concern — whether it is the persistent pigmentation that no serum has moved, the dullness that makes them look more tired than they feel, or the uneven texture that foundation never quite conceals — have already tried a version of the solution themselves. The brightening cleanser. The over-the-counter AHA toner. The vitamin C serum they read about online. Some of it helped, a little, for a while. None of it solved the problem.
What those products share is a fundamental limitation: they work only as far as the skin allows them to go. The stratum corneum — the outermost layer of the epidermis — is one of the most effective barriers in biology. It keeps harmful things out, which is valuable. It also limits what gets in, which is clinically significant. The active concentrations in over-the-counter skincare that are legally permitted for consumer use are, by design, too low to produce the depth of skin change that addresses the concerns patients most want to resolve.
A medical-grade dermal peel changes this equation entirely. Applied by a dermatologist at clinical concentrations, using pharmaceutical-grade formulations and the professional knowledge to match each peel to each patient, a dermal peel can reach the skin layers where pigmentation deposits, where sun damage has remodelled the dermal matrix — and initiate changes there that no product applied to the skin surface can replicate. The result is not a cosmetic improvement. It is a clinical one. And at Ministry of Skin, it is always approached as such.
What a Medical Peel Actually Does
The principle behind a dermal peel is the skin's own biology, accelerated and directed. Under normal conditions, the epidermis renews itself completely approximately every 28 days — shedding its outer layers progressively and producing new keratinocytes beneath. This cycle slows with age, UV exposure, and certain skin conditions, allowing damaged, pigmented, or structurally compromised cells to accumulate at the surface and produce the texture and tone irregularities patients notice.
A dermal peel applies a specific acid or combination of actives to the skin surface, loosening the cohesive bonds that hold the damaged outer layers in place and — depending on the depth and formulation of the peel — penetrating to the level where melanin deposits, post-inflammatory changes, and early scar tissue reside. The controlled injury of the peel triggers a wound-healing response in the dermis: fibroblasts activate, collagen synthesis increases, and the skin's regenerative processes are mobilised more completely than the routine renewal cycle achieves alone. What emerges is skin that is cleaner in tone, smoother in texture, and measurably healthier in its biology.
The word "controlled" in that description is not incidental. It is the entire difference between a peel that produces a clinical outcome and one that produces a complication. The depth of a dermal peel, the concentration of its active agents, the skin type and condition it is applied to, the preparation of the skin in the weeks beforehand, and the management of the skin in the days afterward all determine whether the result is what was intended. At Ministry of Skin, these decisions are made by a qualified dermatologist — not delegated to a therapist following a protocol — and they are made individually, for your skin, at your consultation, on that day.
Peel Portfolio
Why the Right Choice Matters
Not all peels are the same, and not all skin concerns require the same peel. The clinical value of Ministry of Skin's peel programme lies in the breadth and specificity of the options available — and in the dermatologist's ability to select, formulate, and apply the most appropriate one for your specific presentation.
Glycolic Acid Peel: uses an alpha-hydroxy acid derived from sugar cane to loosen and remove the outermost layer of dead skin cells, improving radiance, refining texture, reducing mild pigmentation, and stimulating progressive collagen synthesis with a series of sessions. It is the most accessible entry point in our peel portfolio — well-tolerated across skin types, producing visible improvement with minimal downtime — and it is used for patients with dull, congested, or mildly uneven skin who want consistent, cumulative improvement through a regular programme.
Salicylic Acid Peel: works differently, and for different skin. Salicylic acid is a beta-hydroxy acid — oil-soluble where glycolic acid is water-soluble — which means it can penetrate the sebaceous follicle rather than working only at the skin surface. This makes it uniquely effective for oily, congested, and acne-prone skin: it dissolves the sebum and follicular debris that feed comedone formation, carries anti-inflammatory properties that make it tolerable even in active acne, and produces a visible improvement in skin clarity and congestion that no water-soluble peel can achieve for this skin type. It is among the safest peels for darker skin tones, carrying a very low risk of post-peel pigmentation change.
Lactic Acid Peel: is the gentlest entry point in our alpha-hydroxy acid range, and for many patients — particularly those with sensitive, dry, or reactive skin — the most appropriate one. Derived from milk, lactic acid exfoliates at the skin surface while simultaneously drawing moisture into the dermis, making it the only peel that combines renewal with active hydration. It improves radiance, softens superficial pigmentation, and refines skin texture without the irritation risk that accompanies stronger acids. It is particularly well-suited to patients with compromised skin barriers, rosacea-prone skin, or those new to chemical exfoliation.
Arginine Peel: works through a fundamentally different mechanism to acid-based peels — using the amino acid arginine to stimulate nitric oxide production, which in turn improves microcirculation and cellular oxygenation within the dermis. The result is improved skin tone, a measurable increase in radiance, and a quality of luminosity that reflects genuine vascular and cellular activity rather than surface exfoliation alone. It is particularly effective for dull, fatigued skin and for patients whose skin concerns are driven more by lifestyle stress, poor circulation, or metabolic factors than by congestion or pigmentation.
Mandelac Peel: combines mandelic acid — a large-molecule alpha-hydroxy acid derived from bitter almonds — with lactic acid, producing a dual-action peel that exfoliates, hydrates, and addresses pigmentation simultaneously. The larger molecular size of mandelic acid means it penetrates the skin more slowly than glycolic acid, making it significantly better tolerated by sensitive and darker skin types with a very low risk of post-inflammatory hyperpigmentation. It is particularly effective for acne-prone, pigmented, and uneven skin in Indian skin tones — offering the clinical benefits of acid exfoliation with a considerably gentler safety profile.
Dermamelan: is the professional-grade evolution of the Cosmelan system — a targeted depigmentation treatment designed for patients with more complex or resistant pigmentation presentations. Like Cosmelan, it inhibits multiple steps in the melanogenesis pathway simultaneously, but with an updated formulation that addresses a broader spectrum of pigmentation subtypes, including mixed melasma, post-inflammatory hyperpigmentation, and hormonally driven skin discolouration. The protocol mirrors the Cosmelan approach — a single in-clinic mask application followed by a structured home maintenance programme — and delivers progressive, sustained pigmentation correction over 3–6 months. For patients who have not achieved adequate results with conventional lightening treatments, Dermamelan represents a clinically meaningful step forward.
Dermamelan Intimate: applies the proven depigmentation science of the Dermamelan system to a clinical reality that affects a very large number of patients but is rarely openly discussed — pigmentation of the intimate areas, including the bikini line, inner thighs, underarms, and perianal region. Darkening in these areas is extremely common and is driven by chronic friction, hormonal changes, post-inflammatory hyperpigmentation, and shaving or waxing trauma — yet most patients either do not know treatment exists or feel too uncomfortable to ask. Dermamelan Intimate addresses this gap with a formulation specifically adapted for the delicate skin of these regions, delivering visible brightening and evening of skin tone over a structured treatment course. It is performed and overseen entirely within our clinical environment, with the same discretion, privacy, and non-judgement that defines every consultation at Ministry of Skin.
Retinol Peel: represents a meaningful step up in clinical depth and outcome. Retinoic acid — the biologically active form of Vitamin A — stimulates collagen synthesis, normalises the epidermal turnover cycle, reduces acne lesion formation, and addresses the early structural changes of photodamage more comprehensively than surface-acting acids alone. The trade-off is a more significant post-peel shedding period — typically 3–5 days of visible peeling and mild redness — and a pre-treatment preparation programme that our dermatologists recommend for 2–4 weeks beforehand to prime the skin. The results justify the process: improved skin clarity, measurably reduced post-acne scarring, more even pigmentation, and a quality of skin that reflects genuine dermal renewal rather than surface exfoliation alone.
Cosmelan: occupies a category of its own. Developed by mesoestetic — for which Dr. Dhavala holds a Key Opinion Leader designation — it is one of the most comprehensively validated professional depigmentation systems in the world, used in over 90 countries and supported by an extensive body of clinical evidence for its efficacy in melasma, post-inflammatory hyperpigmentation, and other forms of recalcitrant skin pigmentation. Where single-ingredient lightening treatments inhibit one step in the melanogenesis pathway, Cosmelan inhibits multiple steps simultaneously — using a combination of kojic acid, phytic acid, azelaic acid, and ascorbic acid to interrupt melanin synthesis more completely and more durably. The protocol involves a single in-clinic application of the Cosmelan 1 mask by a dermatologist, worn for a specified period before removal at home, followed by a structured maintenance programme using Cosmelan 2 cream daily. Visible pigmentation improvement typically begins within the first few weeks, with significant clearing apparent by 4–8 weeks and continued improvement over 3–6 months of maintenance. For patients who have struggled with persistent pigmentation for years and found every other approach insufficient, Cosmelan is frequently the clinical turning point.
Obagi Blue Peel: uses trichloroacetic acid — TCA — in the proprietary Obagi Blue Base carrier system, which controls the penetration depth and distribution of the acid precisely across the skin surface. TCA peels at the medium-depth penetration achieved by the Obagi system produce significant improvement in photoageing, moderate pigmentation, textural irregularity, and fine lines — representing the most complete single-session resurfacing available within our superficial-to-medium peel range. The skin heals over 5–7 days, initially appearing red and tight before revealing a cleaner, more even surface beneath. Results from a single Obagi Blue Peel can last 12–18 months or longer with appropriate maintenance and daily photoprotection.
Black Peel: is a medium-depth depigmentation peel targeting melanin deposits in the epidermis and superficial dermis — particularly effective for stubborn pigmentation that has resisted superficial treatment, including deep-set melasma, diffuse skin darkening, and post-inflammatory hyperpigmentation settled below the level that glycolic or salicylic peels can reach. It produces progressive, even lightening over a course of treatments with a relatively low recurrence risk compared to more aggressive resurfacing approaches.
Phenol Peel: represents the deepest level of chemical resurfacing available in clinical dermatology — a treatment reserved for patients with significant photoageing, deep static wrinkles, severe textural irregularity, or long-standing pigmentation that has not responded to medium-depth interventions. Phenol penetrates to the level of the reticular dermis, producing a degree of collagen remodelling and skin renewal that no superficial or medium-depth peel can replicate. The trade-off is substantial: a recovery period of 2–3 weeks, a period of significant erythema, and a requirement for meticulous aftercare and long-term photoprotection. It is performed under controlled clinical conditions with appropriate pre-treatment preparation and post-procedure monitoring. For the right patient — those with appropriate skin type, realistic expectations, and the time to recover — a single phenol peel can produce transformative, lasting results that rival surgical resurfacing in their completeness.
Ferulac Peel: is a professional peel system developed around ferulic acid — a powerful plant-derived antioxidant — combined with a range of complementary actives including salicylic acid, mandelic acid, and phytic acid, depending on the formulation used. Its primary strength lies in its ability to address photoageing, oxidative skin damage, and pigmentation simultaneously, making it particularly well-suited to patients whose skin shows the cumulative effects of sun exposure — uneven tone, early structural changes, loss of radiance, and superficial textural irregularity. It is well-tolerated across skin types, carries a low risk profile, and is available in progressive concentrations, allowing the treating dermatologist to tailor the depth of intervention to the patient's skin and concern.
Blemiderm Peel: is a targeted treatment designed specifically for acne-prone and blemish-affected skin — combining keratolytic, anti-inflammatory, and antibacterial actives to address the multiple factors that drive acne simultaneously. It works to decongest blocked follicles, reduce active inflammation, control sebaceous activity, and improve the post-acne skin surface — making it effective both for patients with ongoing active acne and for those managing the aftermath of breakouts in the form of post-inflammatory marks and uneven texture. Its formulation is particularly well-suited to Indian skin, where acne is frequently accompanied by significant post-inflammatory hyperpigmentation that requires concurrent management alongside the acne itself.
Jessner's Peel: is a time-tested medium-depth peel combining salicylic acid, lactic acid, and resorcinol in an ethanol base — three complementary actives that work synergistically to exfoliate, decongest, and lighten more effectively than any single ingredient used alone. First developed in the early twentieth century and refined over decades of clinical use, it has an extensive evidence base for the treatment of acne, acne scarring, melasma, and moderate photoageing. It can be used as a standalone treatment or as a preparatory step before TCA application to enhance penetration depth and evenness. It produces 5–7 days of visible peeling, with results that reflect meaningful dermal as well as epidermal renewal. It is a cornerstone of clinical peel practice precisely because its outcomes are consistent, its indications are broad, and its long clinical track record makes its behaviour in different skin types well understood.
Purity Luxe: is a brightening and skin quality peel designed for patients who want visible improvement in radiance and clarity without the recovery of a medium-depth peel — combining exfoliating and illuminating actives in a single comfortable session with minimal downtime. It is used for skin maintenance, pre-event preparation, and as a complement to other ongoing skin treatments.
Results, Realistic Expectations, and the Role of Sun Protection
Peel results are cumulative and progressive — each session building on the last, with the skin's response improving as the cumulative effect of collagen stimulation, improved cell turnover, and reduced pigmentation accumulates. For superficial peels, most patients notice a meaningful improvement in radiance and skin clarity within the first 5–7 days of their initial session, with optimal results over a course of 4–6 sessions spaced 2–4 weeks apart. For medium-depth peels, the more significant skin renewal produces more dramatic improvement — visible within 2–3 weeks of a single treatment and lasting considerably longer. Cosmelan produces its most significant results progressively over 3–6 months of the combined in-clinic and home maintenance protocol.
There is, however, one factor that determines more than any other whether peel results last: sun protection. Freshly peeled skin is more susceptible to UV damage, and UV exposure is the primary driver of the pigmentary and structural changes that peels are used to address. Daily broad-spectrum SPF 50+ application — not occasionally, not in summer, but every day, year-round — is not a recommendation we make as a professional suggestion. It is a clinical requirement. Without it, the investment of a peel programme is systematically undermined. At Ministry of Skin, we discuss this clearly at every consultation, because we want the results we produce to last — and that requires the same commitment from our patients that we bring to the treatment itself.
Clients
Testimonials
Frequently Asked Questions
How many sessions will I need to see a real difference?
This depends on your concern and the peel recommended. Superficial peels for maintenance and mild pigmentation typically require 4–6 sessions spaced 2–4 weeks apart for optimal cumulative improvement — with visible change from the first session and progressive enhancement with each subsequent one. For the Cosmelan protocol, visible pigmentation improvement typically becomes apparent within 4–8 weeks of the in-clinic application, with continued improvement over 3–6 months of home maintenance. Medium-depth peels including Obagi Blue can produce significant improvement from a single treatment. Your dermatologist will advise on a specific programme based on your skin assessment and the realistic timeline for your concern.
Are dermal peels safe for dark Indian skin tones?
Yes — when selected and applied correctly by a dermatologist with specific expertise in treating darker skin. The key consideration is matching the peel to the Fitzpatrick type and managing the post-peel period appropriately. Superficial peels, particularly salicylic acid, are very well-tolerated across all Indian skin tones. Deeper peels require more careful selection and post-peel management to minimise the risk of post-inflammatory hyperpigmentation. At Ministry of Skin, this assessment is a routine part of every peel consultation — never an afterthought.
Will a peel make my pigmentation worse before it gets better?
Some patients experience a brief period of apparent worsening in the first few days following a peel — as the superficial pigmented skin cells are shed simultaneously, they can temporarily appear more concentrated before they clear. This is a normal and expected part of the process for pigmentation peels, and it resolves as the skin renews. For deeper peels, there is a more significant transition period during which the skin is healing and the improvement is not yet fully visible. Your dermatologist will prepare you for the expected timeline and explain what to watch for between sessions.
What is the difference between the Cosmelan peel and other lightening treatments?
Most lightening treatments — topical creams, superficial peels, and many laser protocols — target one specific step in the melanin synthesis pathway, typically tyrosinase inhibition. Cosmelan inhibits multiple steps in the pathway simultaneously, using a combination of active ingredients that collectively produce a more comprehensive and more sustained interruption of melanin production. This multi-point inhibition is why Cosmelan produces results for melasma and stubborn PIH that single-mechanism approaches have not been able to achieve for the same patient. It is also why it is combined with a structured home maintenance protocol — because sustaining the multi-point suppression of melanogenesis over months is as important to the outcome as the in-clinic application.
Can I have a peel alongside other skin treatments?
Yes — and peels are often most effective when incorporated into a broader treatment programme. dermal peels are commonly combined with laser therapy, MNRF, Medifacials, and targeted injectable treatments at Ministry of Skin, with sequencing designed to ensure that each treatment complements rather than conflicts with the others. Your dermatologist will advise on the most appropriate combination and timing based on your overall treatment plan and the specific peels being considered.
